Author:
Magdalena Elizabeth Lang,Timothy Sibanda,Stefan Louw,Jean Damascène Uzabakiriho
Subject
Complementary and alternative medicine,Plant Science,Drug Discovery,Pharmaceutical Science,Pharmacology
Reference68 articles.
1. Abdulhussein A, HattabMutlag S, Khamees AH, Sahib H, Ghazi MF (2018). Evaluation of the antiangiogenic and antioxidant activity of Harpagophytum procumbens (devils claw). Drug Invention Today, 10(4):3542-3545.
2. Almeida MC, Soares SF, Abreu PRC, Jesus LM, Brito LC, Bernardo-Filho M (2007). Protective effects of an aqueous extract of Harpagophytum procumbens upon Escherichia coli strains submitted to the lethal action of stannous chloride. Cell and Molecular Biology (Noisy-le-Grand, France) 53(6):923-927.
3. Alves de Almeida AC, de-Faria FM, Dunder RJ, Manzo LP, Souza-Brito AR, Luiz-Ferreira A (2017). Recent trends in pharmacological activity of alkaloids in animal colitis: potential use for inflammatory bowel disease. Evidence-based complementary and alternative medicine, 2017.
4. Ansari WA, Krishna R, Zeyad MT, Singh S, Yadav AK (2020). Endophytic actinomycete-mediated modulation of defense and systemic resistance confers host plant fitness under biotic stress conditions. In Singh RP, Manchanda G, Maurya IK, Wei Y (Eds.), Microbial Versatility in Varied Environments. Singapore: Springer Nature Singapore Pte Ltd. pp. 167-180.
5. Brendler T (2021). From bush medicine to modern phytopharmaceutical: A bibliographic review of Devils Claw (Harpagophytum spp.). Pharmaceuticals 14:726.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献